The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes

Shanghai Jiao Tong University

Status: Unknown

Conditions: Type 2 Diabetes.

Treatments: Behavioral: The initial assessment of daily insulin dose.

Study type: Interventional

Funder types: Other

Identifiers

NCT02143440

2012273

Details and patient eligibility

About

To investigate the daily dose of insulin in newly diagnosed Chinese type 2 diabetic patients who use the continuous subcutaneous insulin infusion (CSII) as the initial therapy.

Enrollment: 65 patients

Sex: All

Ages: 30 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

All participants with type 2 diabetes, diagnosed by World Health Organization criteria, were recruited from outpatient of the Endocrinology Department in Shanghai Renji Hospital.

Exclusion criteria

Patients who had a history of coronary heart disease, abnormal renal function, active liver disease, chronic metabolic acidosis (including diabetic ketoacidosis), or severe chronic gastrointestinal disease.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

65 participants in 1 patient group

Newly diagnosed type 2 patients

Other group

Description:

The initial assessment of daily insulin dose.

Treatment:

Behavioral: The initial assessment of daily insulin dose.